Sensorcaine

Fresenius Kabi USA, LLC🇺🇸 United States

FDA Page

Effective Date: May 12, 2023
Approval ID: e700eb7b-8b14-49c9-96b2-331f18776e45
Products: 2 registered
Version: 7

Regulatory Information

Labeling Type

HUMAN PRESCRIPTION DRUG LABEL

Status

Approved

Full Title

These highlights do not include all the information needed to use SENSORCAINE-MPF, SENSORCAINE-MPF WITH EPINEPHRINE, SENSORCAINE, and SENSORCAINE WITH EPINEPHRINE, safely and effectively. See full prescribing information for SENSORCAINE-MPF, SENSORCAINE-MPF WITH EPINEPHRINE, SENSORCAINE, and SENSORCAINE WITH EPINEPHRINE. SENSORCAINE-MPF (bupivacaine hydrochloride) injection, for infiltration, perineural, caudal, epidural, or retrobulbar useSENSORCAINE-MPF WITH EPINEPHRINE (bupivacaine hydrochloride and epinephrine) injection, for infiltration, perineural, caudal, epidural, or retrobulbar useSENSORCAINE (bupivacaine hydrochloride) injection, for infiltration, perineural useSENSORCAINE WITH EPINEPHRINE (bupivacaine hydrochloride and epinephrine) injection, for infiltration, perineural useInitial U.S. Approval: 1972

Quick Stats

Total Products2

Labelers2

Label Sections19

Regulatory Agency

🇺🇸

U.S. Food and Drug Administration

United States

Data Sources & Disclaimer: Approval information is sourced from official FDA databases. This content is for informational purposes only and does not constitute medical or regulatory advice. Always refer to official FDA websites for the most current information.